FW: WPI on CDC test

[Guest guest]

http://www.wpinstitute.org/news/docs/XMRV-CDC%20Statementrevisedawfinalawfin

al.pdf

Whittemore Institute Statement regarding

Centers for Disease Control XMRV Study

Contrary to the WPI study published in Science in October, 2009, as well as

studies done by

others, including the NIH and FDA, Mr. Switzer of the Centers for

Disease Control reported

that his research team was unable to detect XMRV in CFS patient samples.

This negative finding is in

contrast to the WPI study in which we detected XMRV in 67% of CFS patient

samples.

To correctly replicate scientific studies it is imperative that researchers

use the same methods

and patient criteria to ensure accurate results. The methodology used by the

CDC was not the same as

that used in the WPI study nor was the patient selection criteria. In

September 2009, WPI sent the CDC

twenty confirmed positive samples and the appropriate methodology to help

them develop a clinically

validated test. However, this team chose not to do this.

Until researchers use clinically validated tests to detect XMRV in patient

samples, as WPI

and their collaborators have successfully done, an accurate association of

XMRV to any diseased

population cannot be made. For this reason, WPI researchers and many others

are currently validating

more sensitive clinical assays to assist federal agencies in their search

for the true prevalence of XMRV

in the human population.

WPI will continue its core mission to deliver answers to patients with

neuro-immune diseases

by supporting the development of accurate diagnostics and providing

effective therapeutics and clinical

care.

[Guest guest]

Thank You for posting this.

This whole game seems similar to children that are playing hide and seek. The

CDC is " it " is really does not want to play.

The effort put into " Not Finding Something " is very different and much easier

than finding it! In this case the CDC took their ball and went home before the

game got going, unfortunately they stole the health of a million or more

suffering Americans with their childish behavior. If the US wanted to reform

health care they should have started at the top and worked their way down.

Reform the CDC and we would see billions in savings. Does anyone know what

Medicare/Medicaid spends on unnecessary Phsyc services? In the private sector

treating chronic or incurable illnesses is much more lucrative than finding

cures!

From: Neno/Natasa <neno@...>

Subject: FW: WPI on CDC test

" " < >

Date: Friday, July 2, 2010, 4:33 PM

 

http://www.wpinstitute.org/news/docs/XMRV-CDC%20Statementrevisedawfinalawfin

al.pdf

Whittemore Institute Statement regarding

Centers for Disease Control XMRV Study

Contrary to the WPI study published in Science in October, 2009, as well as

studies done by

others, including the NIH and FDA, Mr. Switzer of the Centers for

Disease Control reported

that his research team was unable to detect XMRV in CFS patient samples.

This negative finding is in

contrast to the WPI study in which we detected XMRV in 67% of CFS patient

samples.

To correctly replicate scientific studies it is imperative that researchers

use the same methods

and patient criteria to ensure accurate results. The methodology used by the

CDC was not the same as

that used in the WPI study nor was the patient selection criteria. In

September 2009, WPI sent the CDC

twenty confirmed positive samples and the appropriate methodology to help

them develop a clinically

validated test. However, this team chose not to do this.

Until researchers use clinically validated tests to detect XMRV in patient

samples, as WPI

and their collaborators have successfully done, an accurate association of

XMRV to any diseased

population cannot be made. For this reason, WPI researchers and many others

are currently validating

more sensitive clinical assays to assist federal agencies in their search

for the true prevalence of XMRV

in the human population.

WPI will continue its core mission to deliver answers to patients with

neuro-immune diseases

by supporting the development of accurate diagnostics and providing

effective therapeutics and clinical

care.